Clinical Trials Directory

Trials / Completed

CompletedNCT01010659

The Safety and Efficacy of Lacrimal Silicone Intubation for the Management of Epiphora

Prospective Clinical Evaluation of Dacryocystorhinostomy (DCR) With Lacrimal Intubation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Aurolab · Academic / Other
Sex
All
Age
15 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of study is to investigate the safety and efficacy of lacrimal silicone intubation for the management of epiphora.

Detailed description

Epiphora is an overflow of tears,usually caused by insufficient drainage of the tear film from the eye.The most common cause is a blockage of the lacrimal ducts located next to the nose, but the condition may also result from the excessive production of tears. Epiphora is a symptom rather than a disease and may be caused by a variety of conditions. 30 subjects will be recruited for this study, informed consent will be taken from the willing subjects. Complete ophthalmic evaluation would be performed including visual acuity. Diagnosis would be made on history of epiphora, regurgitation test, lids examination, nasal examination, probing and syringing. Standard procedure of Dacryocystorhinostomy (DCR) would be adopted in all cases with lacrimal intubation. Syringing will be done on first follow up visit and skin sutures will also be removed. Tightness and mobility of the silicone tube will be checked. The tube is kept in place for 3-6 months according to need and then finally removed. The patency of lacrimal passage will be investigated by irrigation. A successful outcome will be defined as resolution of symptoms like epiphora and discharge and a patent lacrimal system on irrigation.

Conditions

Interventions

TypeNameDescription
DEVICELacrimal TubeLacrimal Tube

Timeline

Start date
2009-11-01
Primary completion
2011-03-01
Completion
2011-06-01
First posted
2009-11-10
Last updated
2011-07-15

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01010659. Inclusion in this directory is not an endorsement.